GENOPIS

Mark For: GENOPIS™ trademark registration is intended to cover the categories of (Based on Intent to Use) pharmaceutical and veterinary preparations, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; chemical preparations for pharmaceutical purposes, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; chemical preparations for use in DNA analysis for medical purposes; drugs for medical purposes, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; reagents for use in medical genetic testing for medical use; pharmaceutical preparations for diagnosis; pharmaceutical preparations for the treatment of immune system related diseases and disorders; ethical medicinal preparations, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; therapeutic drugs and agents, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; reagents for use in veterinary genetic testing for medical use. [all]

Research	OneLook Acronym Finder
Serial Number	88126908
Mark Literal Elements	GENOPIS
Mark Drawing Type	4 - STANDARD CHARACTER MARK
Mark Type	TRADEMARK. SERVICE MARK
Register	PRINCIPAL
Current Location	TMO LAW OFFICE 117 2020-11-03
Basis	1(b)
Class Status	ACTIVE
Primary US Classes	006: Chemicals and Chemical Compositions 018: Medicines and Pharmaceutical Preparations 044: Dental, Medical and Surgical Appliances 046: Foods and Ingredients of Foods 051: Cosmetics and Toilet Preparations 052: Detergents and Soaps
Primary International Class	005 - Primary Class (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed Use	No
Current Use	No
Intent To Use	Yes
Filed ITU	Yes
44D Filed	Yes
44E Current	No
66A Current	No
Current Basis	No
No Basis	No
Attorney Name	Connie L. Ellerbach
Attorney Docket Number	33730-00070
Law Office Assigned	M80
Employee Name	MAI, TINA HSIN

Timeline

2018-09-21	Application Filed
2019-01-03	Location: TMO LAW OFFICE 117
2019-01-03	Status: Live/Pending
2019-01-04	Transaction Date
2020-11-03	Location: TMO LAW OFFICE 117
2021-02-10	Status: Abandoned because the applicant filed an express abandonment. To view all documents in this file, click on the Trademark Documen

Party:	HELIXMITH CO., LTD
Address	1 GWANAK-RO 5TH FL. BLDG. 203 SEOUL KOREA, REPUBLIC OF 08826
Legal Entity Type	Corporation
Legal Entity State	KOREA, REPUBLIC OF

Party:	ViroMed Co., Ltd.
Address	1 Gwanak-ro 5th Fl. Bldg. 203 Seoul KR 08826
Legal Entity Type
Legal Entity State	KR

*multiple parties listed, check assignment documents for ownership information

Drawing	JPEG	2018-09-21
TEAS RF New Application	MULTI	2018-09-21
Offc Action Outgoing	MULTI	2019-01-05
Offc Action Outgoing	XML	2019-01-05
Offc Action Outgoing	XML	2019-01-05
XSearch Search Summary	XML	2019-01-05
Response to Office Action	XML	2019-03-05
Amendment and Mail Process Complete	MULTI	2019-03-06
Suspension Letter	XML	2019-03-07
Change Address or Representation Form	XML	2021-02-08
Express Abandonment	APPLICATION/XML	2021-02-09
Notice of Abandonment	APPLICATION/XML	2021-02-10

CONNIE L. ELLERBACH
FENWICK & WEST LLP
801 CALIFORNIA STREET
SILICON VALLEY CENTER
MOUNTAIN VIEW, CA 94041

(ABANDONED)
IC 005. US 006 018 044 046 051 052. G & S: (Based on Intent to Use) pharmaceutical and veterinary preparations, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; chemical preparations for pharmaceutical purposes, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; chemical preparations for use in DNA analysis for medical purposes; drugs for medical purposes, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; reagents for use in medical genetic testing for medical use; pharmaceutical preparations for diagnosis; pharmaceutical preparations for the treatment of immune system related diseases and disorders; ethical medicinal preparations, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; therapeutic drugs and agents, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; reagents for use in veterinary genetic testing for medical use(ABANDONED)
IC 035. US 100 101 102. G & S: (Based on Intent to Use and Section 44(d)) Retail store services featuring reagents for use in veterinary genetic testing; retail store services featuring chemical preparations for pharmaceutical purposes; retail store services featuring chemical preparations for use in DNA analysis for medical use; retail store services featuring drugs for medical purposes; retail store services featuring reagents for use in medical genetic testing; retail store services featuring pharmaceutical preparations for diagnosis; retail store services featuring pharmaceutical preparations for the treatment of immune system related diseases and disorders; retail store services featuring ethical medicinal preparations; retail store services featuring therapeutic drugs and agents(ABANDONED)
IC 042. US 100 101. G & S: (Based on Intent to Use and Section 44(d)) Research and development of vaccines and medicines; providing information relating to scientific analysis of the genetic information via online networks; scientific research in the fields of biomedicine; biological information analysis, namely, genetic testing for medical research purposes; biological information analysis, namely, genetic testing for scientific research purposes; research and testing services in the fields of bacteriology and virology; drug discovery services; research and development in the pharmaceutical and biotechnology fields; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; consultancy relating to the pharmaceutical research and development; pharmaceutical research and development; pharmaceutical research services; laboratory research in the field of gene expression; gene analysis for research; consultancy in analysis of biology sequence processing for medical research purposes; consultancy in analysis of genomics for medical research purposes; scientific research in the fields of medicine/health and pharmacology; analysis of human serum for medical research; analysis of human tissues for medical research; blood analysis services

International Codes:	5
U.S. Codes:	006,018,044,046,051,052
International Codes:	35
U.S. Codes:	100,101,102
International Codes:	42
U.S. Codes:	100,101

Type Code

Type

GS0421

(Based on Intent to Use and Section 44(d)) Research and development of vaccines and medicines; providing information relating to scientific analysis of the genetic information via online networks; scientific research in the fields of biomedicine; biological information check (genetic testing for medical research purposes); biological information check (genetic testing for scientific research purposes); research and testing services in the fields of bacteriology and virology; drug discovery services; research and development in the pharmaceutical and biotechnology fields; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; consultancy relating to the pharmaceutical research and development; pharmaceutical research and development; pharmaceutical research services; laboratory research in the field of gene expression; gene analysis; consultancy in analysis of biology sequence processing for medical research purposes; consultancy in analysis of genomics for medical research purposes; scientific research in the fields of medicine/health and pharmacology; analysis of human serum for medical research; analysis of human tissues for medical research; blood analysis services

Description	Date	Proceeding Number
ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT	2021-02-10
ABANDONMENT - EXPRESS MAILED	2021-02-10
TEAS EXPRESS ABANDONMENT RECEIVED	2021-02-09
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED	2021-02-08
TEAS CHANGE OF OWNER ADDRESS RECEIVED	2021-02-08
TEAS CHANGE OF CORRESPONDENCE RECEIVED	2021-02-08
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED	2021-02-08
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED	2021-02-08	88888
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED	2020-11-03	70138
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED	2020-04-22	70138
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED	2019-10-01
LIE CHECKED SUSP - TO ATTY FOR ACTION	2019-10-01	70138
ASSIGNED TO LIE	2019-09-26	70138
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP	2019-06-19
SUSPENSION LETTER WRITTEN	2019-03-07	83173
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED	2019-03-07	6332
LETTER OF SUSPENSION E-MAILED	2019-03-07	6332
TEAS/EMAIL CORRESPONDENCE ENTERED	2019-03-05	88889
TEAS RESPONSE TO OFFICE ACTION RECEIVED	2019-03-05
CORRESPONDENCE RECEIVED IN LAW OFFICE	2019-03-05	88889
NOTIFICATION OF NON-FINAL ACTION E-MAILED	2019-01-05	6325
NON-FINAL ACTION WRITTEN	2019-01-05	83173
NON-FINAL ACTION E-MAILED	2019-01-05	6325
ASSIGNED TO EXAMINER	2019-01-03	83173
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM	2018-09-27
NEW APPLICATION ENTERED IN TRAM	2018-09-25